{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:19:48Z","timestamp":1761488388538},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,2,12]],"date-time":"2010-02-12T00:00:00Z","timestamp":1265932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2010,2,12]],"date-time":"2010-02-12T00:00:00Z","timestamp":1265932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s10637-010-9396-4","type":"journal-article","created":{"date-parts":[[2010,2,11]],"date-time":"2010-02-11T02:31:41Z","timestamp":1265855501000},"page":"680-687","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Escalating weekly doses of cetuximab and correlation with skin toxicity: A phase I study"],"prefix":"10.1007","volume":"29","author":[{"given":"Cheryl","family":"Ho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randeep","family":"Sangha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurel","family":"Beckett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derick H.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel B.","family":"Eisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel A.","family":"Burich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Luciw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imran","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip C.","family":"Mack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Gandara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela M.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,2,12]]},"reference":[{"key":"9396_CR1","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1200\/JCO.2003.01.504","volume":"21","author":"J Mendelsohn","year":"2003","unstructured":"Mendelsohn J, Baselga J (2003) Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. J Clin Oncol 21:2787\u20132799","journal-title":"J Clin Oncol"},{"key":"9396_CR2","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.ejca.2005.03.018","volume":"41","author":"APD Tos","year":"2005","unstructured":"Tos APD, Ellis I (2005) Assessing epidermal growth factor receptor expression in tumours: what is the value of current test methods? Eur J Cancer 41:1383\u20131392","journal-title":"Eur J Cancer"},{"key":"9396_CR3","first-page":"4322","volume":"53","author":"Z Fan","year":"1993","unstructured":"Fan Z, Masui H, Altas I et al (1993) Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies. Cancer Res 53:4322\u20134328","journal-title":"Cancer Res"},{"key":"9396_CR4","first-page":"511","volume":"1","author":"JD Sato","year":"1983","unstructured":"Sato JD, Kawamoto T, Le AD et al (1983) Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors. Mol Biol Med 1:511\u2013529","journal-title":"Mol Biol Med"},{"key":"9396_CR5","doi-asserted-by":"publisher","first-page":"5235","DOI":"10.1200\/JCO.2005.00.6916","volume":"23","author":"R Perez-Soler","year":"2005","unstructured":"Perez-Soler R, Saltz L (2005) Cutaneous adverse effects with HER1\/EGFR-targeted agents: is there a silver lining? J Clin Oncol 23:5235\u20135246","journal-title":"J Clin Oncol"},{"key":"9396_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European organization for research and treatment of cancer, national cancer institute of the United States, national cancer institute of Canada. J Natl Cancer Inst 92:205\u2013216","journal-title":"J Natl Cancer Inst"},{"key":"9396_CR7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0190-9622(99)70552-9","volume":"40","author":"JA Witkowski","year":"1999","unstructured":"Witkowski JA, Parish LC (1999) From other ghosts of the past: acne lesion counting. J Am Acad Dermatol 40:131","journal-title":"J Am Acad Dermatol"},{"key":"9396_CR8","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S0190-9622(96)90680-5","volume":"35","author":"AW Lucky","year":"1996","unstructured":"Lucky AW, Barber BL, Girman CJ et al (1996) A multirater validation study to assess the reliability of acne lesion counting. J Am Acad Dermatol 35:559\u2013565","journal-title":"J Am Acad Dermatol"},{"key":"9396_CR9","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1046\/j.1365-4362.1997.00099.x","volume":"36","author":"A Doshi","year":"1997","unstructured":"Doshi A, Zaheer A, Stiller MJ (1997) A comparison of current acne grading systems and proposal of a novel system. Int J Dermatol 36:416\u2013418","journal-title":"Int J Dermatol"},{"key":"9396_CR10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/cyto.b.20452","volume":"76","author":"IH Khan","year":"2009","unstructured":"Khan IH, Krishnan VV, Ziman M et al (2009) A comparison of multiplex suspension array large-panel kits for profiling cytokines and chemokines in rheumatoid arthritis patients. Cytometry B Clin Cytom 76:159\u2013168","journal-title":"Cytometry B Clin Cytom"},{"key":"9396_CR11","unstructured":"US Department of Health and Human Services: Common terminology criteria for adverse events (CTCAE) version 3.0. National Institutes of Health, National Cancer Institute, 2003"},{"key":"9396_CR12","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1056\/NEJMoa071834","volume":"357","author":"DJ Jonker","year":"2007","unstructured":"Jonker DJ, O\u2019Callaghan CJ, Karapetis CS et al (2007) Cetuximab for the treatment of colorectal cancer. N Engl J Med 357:2040\u20132048","journal-title":"N Engl J Med"},{"key":"9396_CR13","first-page":"4055","volume":"27","author":"I Koza Sr","year":"2009","unstructured":"Koza I Sr, Wrba F, Vrbanec D et al (2009) Correlation of KRAS status with clinical outcome in patients (pts) with metastatic colorectal cancer (mCRC) treated first-line with FOLFOX6 + cetuximab (FX+C) or FOLFIRI + cetuximab (FF+C): The CECOG\/CORE1.2.001 trial. ASCO Meeting Abstracts 27:4055","journal-title":"ASCO Meeting Abstracts"},{"key":"9396_CR14","doi-asserted-by":"publisher","first-page":"8646","DOI":"10.1200\/JCO.2005.02.4646","volume":"23","author":"B Burtness","year":"2005","unstructured":"Burtness B, Goldwasser MA, Flood W et al (2005) Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in Metastatic\/Recurrent head and neck cancer: an eastern cooperative oncology group study. J Clin Oncol 23:8646\u20138654","journal-title":"J Clin Oncol"},{"key":"9396_CR15","first-page":"204","volume":"22","author":"L Saltz","year":"2003","unstructured":"Saltz L, Kies M, Abbruzzese L et al (2003) The presence and intensity of the cetuximab-induced acne-like rash predicts increased survival in studies across multiple malignancies. Proc Am Soc Clin Oncol 22:204","journal-title":"Proc Am Soc Clin Oncol"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-010-9396-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-010-9396-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-010-9396-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-010-9396-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T04:53:30Z","timestamp":1678510410000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-010-9396-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,12]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["9396"],"URL":"https:\/\/doi.org\/10.1007\/s10637-010-9396-4","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,12]]},"assertion":[{"value":"20 November 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}